Product Details

Risperdal Consta

Risperidone
50 mg
Powder for Injectable Prolonged-Release Suspension
Vial Pack

DIN/PIN/NPN

02255758

Manufacturer

Janssen Inc.

Formulary Listing Date

2008-08-28  

Unit Price

416.6800

Amount MOH Pays

416.6800

Coverage Status

General Benefit

ODB Formulary Therapeutic Classification

Therapeutic Note

Risperidone 50 mg Powder for Injectable Prolonged-Release Suspension in Vial: For the treatment of schizophrenia or schizoaffective disorders in patients who have: A history of non-adherence; AND one of the following: (a) Inadequate control or significant side-effects from two or more formulary oral antipsychotic medications, including at least one atypical agent; OR (b) Inadequate control or significant side-effects from one or more conventional depot antipsychotic agents.

ATC Code

N05AX08

Interchangeable Products

NO  

LU Clinical Criteria

NO  

EAP Criteria

NO

Product Monograph

View Monograph